Crossmark Global Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.77M Buy
6,221
+47
+0.8% +$20.9K 0.04% 350
2025
Q1
$2.99M Sell
6,174
-33
-0.5% -$16K 0.05% 316
2024
Q4
$2.5M Buy
6,207
+341
+6% +$137K 0.05% 343
2024
Q3
$2.73M Sell
5,866
-298
-5% -$139K 0.05% 340
2024
Q2
$2.89M Sell
6,164
-34
-0.5% -$15.9K 0.06% 321
2024
Q1
$2.59M Sell
6,198
-2,291
-27% -$957K 0.05% 358
2023
Q4
$3.45M Buy
8,489
+460
+6% +$187K 0.07% 284
2023
Q3
$2.9M Buy
8,029
+1,267
+19% +$457K 0.07% 302
2023
Q2
$2.39M Buy
6,762
+84
+1% +$29.7K 0.05% 367
2023
Q1
$2.1M Sell
6,678
-2,859
-30% -$901K 0.05% 390
2022
Q4
$2.75M Buy
9,537
+410
+4% +$118K 0.07% 311
2022
Q3
$2.64M Buy
9,127
+371
+4% +$107K 0.07% 290
2022
Q2
$2.47M Sell
8,756
-252
-3% -$71K 0.06% 320
2022
Q1
$2.35M Buy
9,008
+1,267
+16% +$331K 0.05% 361
2021
Q4
$1.7M Sell
7,741
-210
-3% -$46.1K 0.04% 475
2021
Q3
$1.44M Buy
7,951
+15
+0.2% +$2.72K 0.03% 493
2021
Q2
$1.6M Sell
7,936
-1,015
-11% -$205K 0.04% 455
2021
Q1
$1.92M Sell
8,951
-360
-4% -$77.3K 0.05% 387
2020
Q4
$2.2M Sell
9,311
-443
-5% -$105K 0.06% 346
2020
Q3
$2.65M Sell
9,754
-15,207
-61% -$4.14M 0.07% 277
2020
Q2
$7.25M Buy
24,961
+1,237
+5% +$359K 0.21% 118
2020
Q1
$5.65M Buy
23,724
+236
+1% +$56.2K 0.2% 131
2019
Q4
$5.14M Sell
23,488
-3,503
-13% -$767K 0.14% 167
2019
Q3
$4.57M Buy
26,991
+39
+0.1% +$6.61K 0.13% 182
2019
Q2
$4.94M Buy
26,952
+464
+2% +$85.1K 0.14% 182
2019
Q1
$4.87M Sell
26,488
-399
-1% -$73.4K 0.14% 182
2018
Q4
$4.46M Sell
26,887
-1,391
-5% -$230K 0.14% 180
2018
Q3
$5.45M Sell
28,278
-1,014
-3% -$195K 0.14% 178
2018
Q2
$4.98M Sell
29,292
-790
-3% -$134K 0.13% 186
2018
Q1
$4.9M Sell
30,082
-2,513
-8% -$410K 0.13% 200
2017
Q4
$4.89M Buy
32,595
+10,135
+45% +$1.52M 0.12% 216
2017
Q3
$3.42M Buy
+22,460
New +$3.42M 0.09% 272
2016
Q3
$3.42M Buy
+22,460
New +$3.42M 0.09% 272